Multicenter Assessment of Transdermal Therapy in Overactive Bladder With Oxybutynin TDS (MATRIX)
Multicenter Assessment of Transdermal Therapy in Overactive Bladder With Oxybutynin TDS (MATRIX)
This study evaluates changes in health related quality of life outcomes in patients using Oxytrol(r)
Inclusion Criteria:
Exclusion Criteria: